Your Location：Home >Products >157115-85-0
Product Details
|
157115-85-0 Name |
|
|
Name |
(S)-Ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxamido)acetate |
|
Synonym |
Noopept;ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate;N-(1-(Phenylacetyl)-L-prolyl)glycine ethyl ester;Ethyl 1-(phenylacetyl)-L-prolylglycinate;noopept powder;Nootropic GVS-111;(S)-ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxaMido)acetate;SGS 111 |
|
157115-85-0 Chemical & Physical Properties |
|
|
Melting point |
94.0 to 98.0 °C |
|
Boiling point |
547.3±50.0 °C at 760 mmHg |
|
Density |
1.2±0.1 g/cm3 |
|
Molecular Formula |
C17H22N2O4 |
|
Molecular Weight |
318.368 |
|
Flash Point |
284.8±30.1 °C |
|
PSA |
75.71000 |
|
LogP |
1.28 |
|
Exact Mass |
318.157959 |
|
Vapour Pressure |
0.0±1.5 mmHg at 25°C |
|
Index of Refraction |
1.549 |
|
157115-85-0 Description |
|
Noopept is the brand name for N-phenylacetyl-L-prolylglycine ethyl ester , a synthetic nootropic molecule. It has a similar effect to piracetam, in that it provides a mild cognitive boost after supplementation. It also provides a subtle psychostimulatory effect. Noopept is up to 1000-times more potent than the original racetam, Piracetam. |
|
157115-85-0 Uses |
|
Noopept is a well-known nootropic that is often suggested as a first nootropic.Noopept is over 500 times more potentthan Piracetam.Like piracetam,it is capable of enhancing memory,learning,andfocus. Noopept is also a powerful antioxidant that prevents neurological disorders andhelps the brain grow.Because of this, it is thought to improve long-term memory. The human studies have shown promising results, with potential application in the treatment of Alzheimer's disease. |
Eaters and amides of a series of N-acylprolyl-containing dipeptides were synthesized. It was established that these substances possess the ability to prevent memory decline evoked by maximal electroshock (MES) in a passive avoidance step-through paradigm. These N-acylprolyl-containing dipeptides were designed as analogues of pyroglutamyl-containing dipeptides, which we previously demonstrated to be highly active nootropics.
;
CAS：705-60-2
CAS：73-31-4
CAS：2363-59-9
CAS：9002-07-7
